Neil Brody, MD, PhD, FAAD
- Medical school: New York University School of Medicine
- Residency: Dermatology, New York University Medical Center
- Certifications: Board Certified in Dermatology
Dr. Neil Brody is a Clinical Professor at SUNY Downstate, where he has taught dermatology residents for close to 40 years. Dr. Brody completed his undergraduate degree at Boston University. He subsequently attended New York University School of Medicine, where he earned a Doctorate of Philosophy (PhD) in Immunology and a Doctor of Medicine degree (MD). Dr. Brody also completed his Dermatology residency training at New York University. He came to Suny DMC with Dr Shalita in 1975 and helped grow the dept from a one person division of medicine to ones of the largest dept of derm in the country. He established and ran the in-patient and consult services University hospital for 15 years, established one of the first outpatient phototherapy units and was the first laser officer at SUNY-DMC.
Dr. Brody has been involved in groundbreaking research in numerous facets of dermatology and immunology. Throughout the years, he has been the principal investigator on a variety of clinical and basic science research studies, in areas as diverse as tumor immunology, psoriasis, lasers, anti-oxidants, actinic keratoses, photoaging, and melanoma. Early in his career he discovered and characterized a factor produced by melanoma that thwarts the immune response thus enhancing melanoma progression. He developed an animal model to demonstrate that UVA decreased resistance to melanoma. More recent work focused on developing effective topical antioxidants that can effectively reduce facial erythema and treat acne.
Dr. Brody has received countless accolades for his accomplishments in medicine and research, including an American Cancer Society Grant, the HUSIG Prize in Dermatology Research, a Society for Investigative Dermatology Fellowship, NIH and other research grants. Dr. Brody is an avid speaker and has given numerous lectures, both nationally and internationally.
For over 30 years, he also has run a successful dermatology private practice in Manhasset, New York including a psoriasis care center and laser center.
- Jagdeo J, Brody N. Complementary anti-oxidant function of caffeine and green tea polyphenols demonstrated via modulation of reactive oxygen species and 4-hydroxy-2-nonenal in normal human skin fibroblasts in vitro. Accepted January 2011
- Jagdeo J, Adams L, Siegel D, Brody NI. Transcranial Red and Near Infrared Light Transmission in a Cadaveric Model. PLoS One. 2012;7(10)e47460. doi: 10.1371/journal.pone.0047460. Epub 2012 Oct. 15.
- Silverberg JI, Jagdeo J, Patel, Siegel D, Brody N. Green tea extract protects human skin fibroblasts from reactive oxygen species induced necrosis. J Drugs Dermatol. 2011 Oct1;10(10):1096-101.
- Hadar Lev-Tov, MD, Neil Brody, MD, PhD, Daniel Siegel MD, MS, and Jared Jagdeo, MD, MS. Inhibition of Fibroblast Proliferation In Vitro Using Low-Level Infrared Light-Emitting Diodes. Accepted Dermatologic Surgery - DSU-12087, 2012.
- Hadar Lev-Tov, MD, Neil Brody, MD, PhD, Daniel Siegel MD, MS, and Jared Jagdeo, MD, MS. Inhibition of Fibroblast Proliferation In Vitro Using Red Light Emitting Diodes. Accepted Dermatologic Surgery – DS-00854-2012.R1.
- M. Serravallo, J. Jagdeo, S. A. Glick, D. M. Siegel, N. I. Brody. Sirtuins in Dermatology: Applications for Future Research and Therapeutics. Archives of Dermatology Research, DOI 10.1007/s00403-013-1320-2. Accepted January 2013.
- Georgina Ferzil, MD, MS, Mital Patel MD, Natasha Phrsai BS, and Neil Brody MD, PhD. Reduction of Facial Redness with Resveratrol Added to Topical Product Containing Green Tea Polyphenols and Caffeine. Accepted Journal of Drugs in Dermatology. June 2013.
- Andrew Mamalis BS, Duc-Huy Nguyen, Neil Brody MD, PhD, and Jared Jagdeo MD, MS. Dermatologists' Knowledge of and Preferences Regarding Topical Steroids. Laura F. Sandoval DO, Scott A. Davis MA, and Steven R. Feldman MD, PhD. The Active Natural Anti-Oxidant Properties of Chamomile, Milk Thistle, and Halophilic Bacterial Components in Human Skin In Vitro. Accepted Journal of Drugs in Dermatology. June 2013.
- Andrew Mamalis, Natallia Fiadorchanka, Lauren Adams, Melissa Serravallo, Edward Heilman, Daniel Siegel, Neil Brody, Jared J. Jagdeo. Immunohistochemical Assessment of Ultraviolet radiation Damage in Skin. Accepted PLOS ONE. October 2013.
- Andrew Mamalis, Natallia Fiadorchanka MD, Lauren Adams MD, Melissa Serravallo MD, Edward Heilman MD, Daniel Siegel MD, MS, Neil Brody MD, PhD, Jared J. Jagdeo MD, MS. An Immunohistochemical Panel to Assess Ultraviolet Radiation-Associated Oxidative Skin Injury. Accepted Journal of Drugs in Dermatology. April 2014.